Macroscale delivery systems for molecular and cellular payloads.
暂无分享,去创建一个
[1] Klaus Mosbach,et al. Drug assay using antibody mimics made by molecular imprinting , 1993, Nature.
[2] L. Chandler,et al. Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] D J Mooney,et al. Alginate hydrogels as synthetic extracellular matrix materials. , 1999, Biomaterials.
[4] K. Smetana. Cell biology of hydrogels. , 1993, Biomaterials.
[5] Gregg W. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease , 2004 .
[6] David J Mooney,et al. Cell delivery mechanisms for tissue repair. , 2008, Cell stem cell.
[7] P. Janmey,et al. Fibrin gels and their clinical and bioengineering applications , 2009, Journal of The Royal Society Interface.
[8] Eben Alsberg,et al. Engineering growing tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] B Mattiasson,et al. 'Smart' polymers and what they could do in biotechnology and medicine. , 1999, Trends in biotechnology.
[10] David J Mooney,et al. Effects of VEGF temporal and spatial presentation on angiogenesis. , 2010, Biomaterials.
[11] Philip R. Kuhl,et al. Tethered epidermal growth factor as a paradigm for growth factor–induced stimulation from the solid phase , 1996, Nature Medicine.
[12] Robert Langer,et al. First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip , 2012, Science Translational Medicine.
[13] Guixue Wang,et al. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents. , 2011, Journal of vascular surgery.
[14] C. Alvarez‐Lorenzo,et al. Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities. , 2005, Macromolecular bioscience.
[15] J. M. Badura,et al. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft) , 2007, International Orthopaedics.
[16] D. Mooney,et al. Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentration , 2002 .
[17] J. Jansen,et al. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. , 2005, Journal of biomedical materials research. Part A.
[18] J. Leroux,et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. , 2000, Biomaterials.
[19] Patrick Couvreur,et al. Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.
[20] Bradley K Weiner,et al. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.
[21] Takashi Miyata,et al. A reversibly antigen-responsive hydrogel , 1999, Nature.
[22] K W Anderson,et al. Cell-interactive Alginate Hydrogels for Bone Tissue Engineering , 2001, Journal of dental research.
[23] R Langer,et al. Laminated three-dimensional biodegradable foams for use in tissue engineering. , 1993, Biomaterials.
[24] A. Pandit,et al. The effect of TGF-beta delivered through a collagen scaffold on wound healing. , 1999, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[25] Jennifer L. West,et al. Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells , 2001 .
[26] A. Landesberg,et al. Improved vascular organization enhances functional integration of engineered skeletal muscle grafts , 2011, Proceedings of the National Academy of Sciences.
[27] N. Peppas,et al. Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. II. Diffusion and release studies , 1997 .
[28] M. Spector,et al. Healing of canine articular cartilage defects treated with microfracture, a type‐II collagen matrix, or cultured autologous chondrocytes , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[29] E. L. Crossley. A GENERAL REVIEW , 1954 .
[30] A. Vaccaro,et al. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion , 2007, International Orthopaedics.
[31] M. Kocher,et al. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. , 2003, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[32] B. Feeley,et al. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] H. V. von Recum,et al. Affinity-based drug delivery. , 2011, Macromolecular bioscience.
[34] J. Fiorellini,et al. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a dog model. , 2006, The International journal of periodontics & restorative dentistry.
[35] A. M. Turing,et al. The chemical basis of morphogenesis , 1952, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.
[36] David J Mooney,et al. Alginate hydrogels as biomaterials. , 2006, Macromolecular bioscience.
[37] Paul D. Kessler,et al. Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.
[38] A. Khademhosseini,et al. Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[39] K. Anseth,et al. Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[40] M. Hadamitzky,et al. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial. , 2011, Journal of the American College of Cardiology.
[41] Johnny Huard,et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.
[42] Yoshihiro Ito,et al. Covalently immobilized biosignal molecule materials for tissue engineering. , 2007, Soft matter.
[43] David J. Mooney,et al. Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.
[44] F. Eberli,et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial , 2011, The Lancet.
[45] Y. Tabata,et al. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. , 2003, Biomaterials.
[46] L Claes,et al. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. , 2007, Bone.
[47] W. Pitt,et al. Ultrasonic drug delivery – a general review , 2004, Expert opinion on drug delivery.
[48] Y. Ikada,et al. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. , 2000, Biomaterials.
[49] Hans-Günther Machens,et al. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. , 2009, Tissue engineering. Part A.
[50] Antonios G. Mikos,et al. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. , 2007, Biomaterials.
[51] Horst Kessler,et al. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. , 2003, Biomaterials.
[52] J. Hirsh,et al. Heparin Binding Proteins Contribution to Heparin Rebound After Cardiopulmonary Bypass , 1993, Circulation.
[53] P. Hammond. Form and Function in Multilayer Assembly: New Applications at the Nanoscale , 2004 .
[54] D. Hutmacher,et al. In vivo mesenchymal cell recruitment by a scaffold loaded with transforming growth factor beta1 and the potential for in situ chondrogenesis. , 2002, Tissue engineering.
[55] Robert Langer,et al. INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE , 1980 .
[56] Dean-Mo Liu,et al. Magnetic-sensitive behavior of intelligent ferrogels for controlled release of drug. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[57] H. V. von Recum,et al. Cyclodextrin-based device coatings for affinity-based release of antibiotics. , 2010, Biomaterials.
[58] Robert J Fisher,et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. , 2006, Biomaterials.
[59] D. Kim,et al. Vertical ridge augmentation using an equine block infused with recombinant human platelet-derived growth factor-BB: a histologic study in a canine model. , 2009, The International journal of periodontics & restorative dentistry.
[60] L. Gibson,et al. The effect of pore size on cell adhesion in collagen-GAG scaffolds. , 2005, Biomaterials.
[61] Jeff W Lichtman,et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors , 2009, Proceedings of the National Academy of Sciences.
[62] D. Mooney,et al. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.
[63] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[64] K. Shakesheff,et al. Polymeric systems for controlled drug release. , 1999, Chemical reviews.
[65] L. Lavery,et al. The costs of diabetic foot: the economic case for the limb salvage team. , 2010, Journal of the American Podiatric Medical Association.
[66] D. M. Lynn,et al. Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films , 2006, Proceedings of the National Academy of Sciences.
[67] C. Laurencin,et al. Bone tissue engineering by gene delivery. , 2006, Advanced drug delivery reviews.
[68] P. Gupta,et al. Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.
[69] H. Vandenburgh,et al. The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. , 2011, Biomaterials.
[70] Matthias P. Lutolf,et al. Designing materials to direct stem-cell fate , 2009, Nature.
[71] R Langer,et al. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of Biomedical Materials Research.
[72] T J Roseman,et al. Release of steroids from a silicone polymer. , 1972, Journal of pharmaceutical sciences.
[73] A. Schulz,et al. Mid-term results of Autologous Matrix-Induced Chondrogenesis for treatment of focal cartilage defects in the knee , 2010, Knee Surgery, Sports Traumatology, Arthroscopy.
[74] Jiyoung M Dang,et al. Natural polymers for gene delivery and tissue engineering. , 2006, Advanced drug delivery reviews.
[75] R. Erbel,et al. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[76] Vladimir Mironov,et al. Organ printing: computer-aided jet-based 3D tissue engineering. , 2003, Trends in biotechnology.
[77] M. Einarson. Controlled-release microchip , 1999, Nature Biotechnology.
[78] Daniel Scherman,et al. Growth factor delivery approaches in hydrogels. , 2009, Biomacromolecules.
[79] A. Sun,et al. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. , 1996, The Journal of clinical investigation.
[80] Miqin Zhang,et al. Chitosan-based hydrogels for controlled, localized drug delivery. , 2010, Advanced drug delivery reviews.
[81] David J Mooney,et al. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. , 2005, Biomaterials.
[82] Daniel G. Anderson,et al. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. , 2011, Endocrine reviews.
[83] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .
[84] D E Ingber,et al. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. , 1993, Journal of biomedical materials research.
[85] J. Hubbell,et al. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.
[86] R. Tuan,et al. Technology Insight: adult mesenchymal stem cells for osteoarthritis therapy , 2008, Nature Clinical Practice Rheumatology.
[87] R. Langer,et al. Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.
[88] Peter X. Ma,et al. Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair , 2011, Nature materials.
[89] Yoshimitsu Kuroyanagi,et al. Design of artificial skin , 1996 .
[90] Eben Alsberg,et al. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. , 2004, Bone.
[91] Franz E Weber,et al. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. , 2005, Biotechnology and bioengineering.
[92] T. Guda,et al. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. , 2011, Tissue engineering. Part A.
[93] A. Concheiro,et al. Molecularly imprinted polymers for drug delivery. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[94] J. Kost,et al. Ultrasound-enhanced polymer degradation and release of incorporated substances. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[95] M. Ferguson,et al. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration , 2007, Journal of The Royal Society Interface.
[96] J. Hubbell,et al. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. , 1999, Bioconjugate chemistry.
[97] M. Cima,et al. Mechanical properties of dense polylactic acid structures fabricated by three dimensional printing. , 1996, Journal of biomaterials science. Polymer edition.
[98] I. Yannas,et al. Design of an artificial skin. I. Basic design principles. , 1980, Journal of biomedical materials research.
[99] S. Santavirta,et al. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.
[100] A. Kundu,et al. Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. , 2006, Journal of biomedical materials research. Part A.
[101] R. Fisher,et al. Human hepatocyte transplantation: worldwide results. , 2006, Transplantation.
[102] Dietmar W Hutmacher,et al. Current strategies for cell delivery in cartilage and bone regeneration. , 2004, Current opinion in biotechnology.
[103] Charles A. Vacanti,et al. Transplantation of Chondrocytes Utilizing a Polymer‐Cell Construct to Produce Tissue‐Engineered Cartilage in the Shape of a Human Ear , 1997, Plastic and reconstructive surgery.
[104] A. Metters,et al. Hydrogels in controlled release formulations: network design and mathematical modeling. , 2006, Advanced drug delivery reviews.
[105] R Langer,et al. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. , 1996, Biomaterials.
[106] Paula T Hammond,et al. Electroactive controlled release thin films , 2008, Proceedings of the National Academy of Sciences.
[107] R. Colvin,et al. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[108] B. Blumenthal,et al. Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function. , 2010, Artificial organs.
[109] Robert Langer,et al. Progress in the tissue engineering and stem cell industry "are we there yet?". , 2012, Tissue engineering. Part B, Reviews.
[110] A. Ganser,et al. Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium , 2005, Circulation.
[111] David J. Mooney,et al. Active scaffolds for on-demand drug and cell delivery , 2010, Proceedings of the National Academy of Sciences.
[112] J. Hubbell,et al. Bioactive biomaterials. , 1999, Current opinion in biotechnology.
[113] M. Sefton,et al. Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.
[114] Smadar Cohen,et al. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. , 2008, Biomaterials.
[115] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[116] I. Yannas,et al. Organized skin structure is regenerated in vivo from collagen-GAG matrices seeded with autologous keratinocytes. , 1998, The Journal of investigative dermatology.
[117] S. Boden,et al. THE USE OF BMP-2 IN INTERBODY FUSION CAGES: DEFINITIVE EVIDENCE OF OSTEOINDUCTION IN HUMANS , 2002 .
[118] Gabriela A Silva,et al. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. , 2007, Advanced drug delivery reviews.
[119] Masanori Fujita,et al. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. , 2003, Journal of biomedical materials research. Part A.
[120] Paula T Hammond,et al. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. , 2011, Biomaterials.
[121] Daniel Anderson,et al. Delivery materials for siRNA therapeutics. , 2013, Nature materials.
[122] Anthony Atala,et al. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering , 1999, Nature Biotechnology.
[123] A. Khademhosseini,et al. Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology , 2006 .
[124] Hideo Tanaka,et al. Diffusion characteristics of substrates in Ca‐alginate gel beads , 1984, Biotechnology and bioengineering.
[125] Eun-Suk Kim,et al. Material-based deployment enhances efficacy of endothelial progenitor cells , 2008, Proceedings of the National Academy of Sciences.
[126] David J Mooney,et al. In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice , 2009, Science Translational Medicine.
[127] D. Kohane,et al. HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES , 2008 .
[128] N. Peppas,et al. Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. I. Polymer characterization , 1996 .
[129] M L Cooper,et al. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. , 1991, Biomaterials.
[130] A. Rachkov,et al. Towards molecularly imprinted polymers selective to peptides and proteins. The epitope approach. , 2001, Biochimica et biophysica acta.
[131] S. Boden,et al. The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.
[132] Patrick W Serruys,et al. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[133] E. Edelman,et al. Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery , 2001, Circulation.
[134] D J Mooney,et al. Open pore biodegradable matrices formed with gas foaming. , 1998, Journal of biomedical materials research.
[135] V. Goldberg,et al. Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle. , 1989, Journal of biomedical materials research.
[136] Robert Langer,et al. Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine) , 1993 .
[137] Hai Yao,et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study , 2010, The Lancet.
[138] Ulrich Kneser,et al. Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. , 2005, Tissue engineering.
[139] A. Schindler,et al. Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters. , 1979, Journal of pharmaceutical sciences.
[140] Darrell J Irvine,et al. Engineering synthetic vaccines using cues from natural immunity. , 2013, Nature materials.
[141] W. Hunter,et al. Drug-eluting stents: a multidisciplinary success story. , 2006, Advanced drug delivery reviews.
[142] Jing Zhang,et al. Synthesis and Characterization of pH- and Temperature-Sensitive Poly(methacrylic acid)/Poly(N-isopropylacrylamide) Interpenetrating Polymeric Networks , 2000 .
[143] Michael Joner,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.
[144] K. Sawahata,et al. Electrically controlled drug delivery system using polyelectrolyte gels , 1990 .
[145] U Kneser,et al. Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. , 1999, Journal of biomedical materials research.
[146] Marc Hedrick,et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. , 2005, Tissue engineering.
[147] R. Loeser. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. , 2009, Osteoarthritis and cartilage.
[148] Sanjay Garg,et al. Advanced drug-delivery systems , 2011 .
[149] T. Chang. Artificial liver support based on artificial cells with emphasis on encapsulated hepatocytes. , 2008, Artificial organs.
[150] S. Murdan. Electro-responsive drug delivery from hydrogels. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[151] S. Davis,et al. In vitro evaluation of alginate gel systems as sustained release drug delivery systems , 1986 .
[152] J. Vacanti,et al. Biodegradable sponges for hepatocyte transplantation. , 1995, Journal of biomedical materials research.
[153] H. Vandenburgh,et al. Tissue-engineered skeletal muscle organoids for reversible gene therapy. , 1996, Human gene therapy.
[154] S. Bryant,et al. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. , 2008, Tissue engineering. Part B, Reviews.
[155] Antonios G Mikos,et al. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[156] D. Mooney,et al. Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[157] R. Virmani,et al. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus‐eluting stents in a porcine model of restenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[158] David J Mooney,et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. , 2011, Biomaterials.
[159] David J Mooney,et al. Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones , 2010, Proceedings of the National Academy of Sciences.
[160] Allan S. Hoffman,et al. The origins and evolution of "controlled" drug delivery systems. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[161] W. Harris,et al. Biologic fixation of total hip implants. Insights gained from a series of canine studies. , 2004, The Journal of bone and joint surgery. American volume.
[162] L. Lavery,et al. The costs of diabetic foot: the economic case for the limb salvage team. , 2010, Journal of vascular surgery.
[163] G. Hsiue,et al. Heterobifunctional poly(ethylene glycol)-tethered bone morphogenetic protein-2-stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. , 2007, Tissue engineering.
[164] Cato T Laurencin,et al. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy–cell transplantation approach , 2008, Proceedings of the National Academy of Sciences.
[165] N. Peppas,et al. Hydrogels in Pharmaceutical Formulations , 1999 .
[166] J. Hubbell,et al. Development of growth factor fusion proteins for cell‐triggered drug delivery , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.